JCRB1815 MOLM-16
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB1815 | Cell Name | MOLM-16 |
---|---|---|---|
Profile | Megakaryoblastic leukemia cell line derived from minimally differentiated acute leukemia (AML-M0) with myeloid/NK precursor phenotype. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 77-year-old |
Identity | not done | Tissue for Primary Cancer | |
Case history | minimally differentiated acute leukemia (AML-M0) | Metastasis | |
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | lymphoblast-like | Character | |
Classify | tumor | Established by | Matsuo Y |
Registered by | Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Inc | Regulation for Distribution | |
Comment | The survival and growth seem bo be cell density dependent. 1/2 - 1/4 split is recommended. | Year | |
Medium | RPMI1640 with 10% FBS | Methods for Passages | dilution |
Cell Number on Passage | Race | ||
CO2 Conc. | 5% | Tissue Sampling | |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:12526922 | Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype. Matsuo Y,Drexler HG,Kaneda K,Kojima K,Ohtsuki Y,Hara M,Yasukawa M,Tanimoto M,Orita K Leuk Res. 2003 Feb;27(2):165-71 |
Images |
---|
LOT Information
Cell No. | JCRB1815 | Cell Name | MOLM-16 |
---|---|---|---|
LOT No. | 12202019 | Lot Specification | distribution |
Medium | RPMI1640 medium(GIBCO:Cat No.;11875-093) with 10% heat inactivated fetal bovine serum(SIGMA,Cat#172012,Lot#12J396) | Temperature | 37 C |
Cell Density at Seeding | 0.5-4.0x10^5 cells/ml | Methods for Passages | dilution |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.40x10^6 |
Viability at cell freezing (%) | 94.34 | Antibiotics Used | free |
Passage Number | p8* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:10 D13S317:9,12 D7S820:11,12 D16S539:9 VWA:15,18 TH01:9 AM:X TPOX:8,11 CSF1PO:12 |
Adhesion | No | Exoteric Gene | NT |
Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
Viability immediately after thawing (%) | NT | Additional information |
Images |
---|
Cell No. | JCRB1815 | Cell Name | MOLM-16 |
---|---|---|---|
LOT No. | 09062023 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10437, Lot 1072322) | Temperature | 37 C |
Cell Density at Seeding | 1.9 - 2.3 x 10^5 cells/ml | Methods for Passages | Simple dilution (suspension culture). |
Doubling Time | approx. 50 hrs. | Cell Number in Vial (cells/1ml) | 3.2 x 10^6 |
Viability at cell freezing (%) | 81 | Antibiotics Used | free |
Passage Number | Unknown (11 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:10 D13S317:9,12 D7S820:11,12 D16S539:9 VWA:15,18 TH01:9 AM:X TPOX:8,11 CSF1PO:12 |
|
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 83 | Additional information |